Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Immunovant, Inc. (IMVT)

26.99 -1.63 (-5.70%)
At close: April 28 at 4:00:00 PM EDT
26.32 -0.67 (-2.48%)
Pre-Market: 9:28:00 AM EDT
Trade IMVT on Coinbase
Chart Range Bar
Loading chart for IMVT
  • Previous Close 28.62
  • Open 28.62
  • Bid 20.65 x 200
  • Ask 33.28 x 200
  • Day's Range 26.61 - 29.11
  • 52 Week Range 13.36 - 30.09
  • Volume 2,354,883
  • Avg. Volume 1,424,977
  • Market Cap (intraday) 5.493B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -2.67
  • Earnings Date (est.) May 28, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 40.29

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

immunovant.com

362

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview: IMVT

Trailing total returns as of 4/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMVT
6.18%
S&P 500 (^GSPC)
4.28%

1-Year Return

IMVT
75.03%
S&P 500 (^GSPC)
29.12%

3-Year Return

IMVT
67.22%
S&P 500 (^GSPC)
71.22%

5-Year Return

IMVT
65.08%
S&P 500 (^GSPC)
70.65%

Earnings Trends: IMVT

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue --
Earnings -97.53M

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-120M
-100M
-80M
-60M
-40M
-20M
0

Analyst Insights: IMVT

View More

Analyst Price Targets

22.00
40.29 Average
26.99 Current
66.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/15/2026
Analyst Goldman Sachs
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 29 -> 32

Statistics: IMVT

View More

Valuation Measures

Annual
As of 4/28/2026
  • Market Cap

    5.49B

  • Enterprise Value

    4.78B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    5.57

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -41.33%

  • Return on Equity (ttm)

    -69.35%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -464.2M

  • Diluted EPS (ttm)

    -2.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    994.52M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -260.59M

Compare To: IMVT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: IMVT

Fair Value

26.99 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: IMVT

View More
  • Daily – Vickers Top Buyers & Sellers for 04/14/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/11/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/22/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/30/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: